Merja Haaparanta-Solin
Adj.prof.
MediCity Research Laboratories, PET merja.haaparanta-solin@utu.fi +358 40 715 1742 Tykistökatu 6 Turku |
2 of 15
- Quantification of the purinergic P2X(7) receptor with [C-11]SMW139 improves through correction for brain-penetrating radiometabolites (2023)
- Journal of Cerebral Blood Flow and Metabolism
- Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation (2022)
- EJNMMI Research
- Direct Comparison of [18F]F-DPA with [18F]DPA-714 and [11C]PBR28 for Neuroinflammation Imaging in the same Alzheimer’s Disease Model Mice and Healthy Controls (2022)
- Molecular Imaging and Biology
- ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein (2022)
- Translational Neurodegeneration
- Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11C]SMW139 to explain the high uptake of radiometabolites in mouse brain (2022)
- Journal of Pharmaceutical and Biomedical Analysis
- Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability (2022)
- International Journal of Obesity
- Changes in electrocardiogram parameters during acute nonshivering cold exposure and associations with brown adipose tissue activity, plasma catecholamine levels, and brachial blood pressure in healthy adults (2021)
- Physiological Reports
- Intravenous transplantation of olfactory ensheathing cells reduces neuroinflammation after spinal cord injury via interleukin-1 receptor antagonist (2021)
- Theranostics
- Lihomisriski on yhteydessä aivojen insuliini- ja reseptorimuutoksiin (2021)
- Duodecim
- (S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)
- Neuropharmacology
UTU Research Portal